Meghan D. Duncan
Meghan D. Duncan publishes mostly in Oncology, Radiology, Nuclear Medicine and Imaging and Molecular Biology, on topics such as Cancer Immunotherapy and Biomarkers, CAR-T cell therapy research and Monoclonal and Polyclonal Antibodies Research.
- World rank
- #4,750,413 of 7,710,434 ranked researchers
- Rank in United States
- #1,247,968 of 1,627,098
- Works
- 20
- Citations
- 202
- Citations per work
- 10.1
What does Meghan D. Duncan research?
Meghan D. Duncan's work is mostly in Medicine (66%), Biochemistry, Genetics and Molecular Biology (5%), Health Professions (5%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1471.2%
- Medicine1366.1%
- Health Professions15.1%
- Everything else420.3%
- Life Sciences15.1%
- Physical Sciences13.4%
- Chemistry13.4%
- 1Oncology42% of their works
- 2Radiology, Nuclear Medicine and Imaging20% of their works
- 3Molecular Biology5% of their works
- 4Radiological and Ultrasound Technology5% of their works
- 5Pulmonary and Respiratory Medicine3% of their works
- 6Organic Chemistry3% of their works
Research topics
Which keywords describe Meghan D. Duncan's research?
The keywords of their largest research topics: Tumor Microenvironment, Immunotherapy, Tumor Regression, Immune Checkpoint Blockade, Ionizing Radiation, PD-1 and PD-L1, Cancer Therapy and CAR T Cells.
- Bacterial Therapy
- PARP Inhibitors
- Immunosuppression
- BRCA Mutation
- Computed Tomography
- Fc Receptors
- Cancer Therapy
- PD-1 and PD-L1
- Immune Checkpoint Blockade
- Immunotherapy
- Tumor Microenvironment
- Tumor Regression
- Ionizing Radiation
- CAR T Cells
- Chimeric Antigen Receptor
- Therapeutic Antibodies
- Radiation Exposure
- Fibroblast Activation Protein
- Lung Cancer
- Radon
- Tumor Targeting
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Tumor Microenvironment102 topics
- Immunotherapy82 topics
- Tumor Regression82 topics
- Immune Checkpoint Blockade71 topic
- Ionizing Radiation72 topics
- PD-1 and PD-L171 topic
- CAR T Cells61 topic
- Cancer Therapy62 topics
- Chimeric Antigen Receptor61 topic
- Fc Receptors61 topic
- Therapeutic Antibodies61 topic
- Computed Tomography41 topic
- Radiation Exposure41 topic
- BRCA Mutation31 topic
- Fibroblast Activation Protein31 topic
- Immunosuppression31 topic
- Lung Cancer31 topic
- PARP Inhibitors31 topic
- Radon31 topic
- Bacterial Therapy21 topic
- Tumor Targeting21 topic
Where does Meghan D. Duncan work?
Meghan D. Duncan's main affiliation in the publication record is Xilio Therapeutics (United States), United States.
How many publications and citations does Meghan D. Duncan have?
OpenAlex counts 20 works and 202 citations for Meghan D. Duncan, an h-index of 5, ranking #4,750,413 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Meghan D. Duncan. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.